Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.57 |
| ▸ | DRD2 | P14416 | 2/20 | 0.42 |
| ▸ | DRD4 | P21917 | 2/20 | 0.42 |
| ▸ | DRD3 | P35462 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MIF | P14174 | 5/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | MAP3K9 | P80192 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2316420 | 0.85 | PNMT (0.54) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL7534249 | 0.85 | PNMT (0.54) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL5254177 | 0.81 | DRD2 (0.42) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL8672207 | 0.81 | PNMT (0.53) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL5252581 | 0.80 | PNMT (0.49) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL7886099 | 0.80 | PNMT (0.51) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL896998 | 0.79 | PNMT (0.54) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL3979804 | 0.79 | PNMT (0.67) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL7538016 | 0.79 | PNMT (0.62) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL123076 | 0.79 | PNMT (0.62) | PNMTDRD2DRD4DRD3NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 25642 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382496-A1 | PROCESSES FOR FORMING CROSSLINKED POLYMER FILMS | DUPONT ELECTRONICS INC (US) | 2025-12-18 | — | — | US | claimed |
| US-12404421-B2 | Coating solutions and crosslinked polymer films | DUPONT ELECTRONICS, INC. (US) | 2025-09-02 | — | — | US | claimed |
| CN-118369094-A | Process for preparing substituted pyrazolopyrimidines | KSQ治疗公司 | 2024-07-19 | — | — | CN | claimed |
| CN-114644568-B | Purification method of sitagliptin intermediate | 浙江医药股份有限公司新昌制药厂 | 2024-07-19 | — | — | CN | claimed |
| US-20240240114-A1 | Improved Combination of Protease and Protease Inhibitor with Secondary Enzyme | BASF SE (DE) | 2024-07-18 | — | — | US | claimed |
| EP-3634951-B1 | NOVEL SUBSTITUTED SULFOXIMINE COMPOUNDS | ZYDUS LIFESCIENCES LTD (IN) | 2024-07-10 | — | — | EP | claimed |
| CN-107089993-B | Hypolipidemic activity bamboo-cypress lactone compound, preparation method and application thereof | 中国科学院上海药物研究所 | 2024-07-09 | — | — | CN | claimed |
| CN-111093687-B | Use of peptides as therapeutic agents for autoimmune diseases and bone diseases | 凯恩塞恩斯株式会社 | 2024-07-09 | — | — | CN | claimed |
| CN-111148525-B | Use of peptides as therapeutic agents for autoimmune diseases and bone diseases | 凯恩塞恩斯株式会社 | 2024-07-05 | — | — | CN | claimed |
| CN-113646322-B | Solid phase peptide synthesis method and device | 奥利弗·约翰内斯·克鲁泽 | 2024-07-05 | — | — | CN | claimed |
| US-4732970-A | Antitumor amino acid and peptide derivatives of 1,4-bis(aminoalkyl and hydroxy-aminoalkyl)amino)-5,8-dihydroxyanthraquinones | AMERICAN CYANAMID COMPANY (US) | 1988-03-22 | — | — | US | claimed |
| US-4725581-A | NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS | ADIR ET COMPAGNIE (FR) | 1988-02-16 | — | — | US | claimed |
| EP-0223143-A2 | Analogs of atrial natriuretic peptides | CALIFORNIA BIOTECHNOLOGY, INC. (US) | 1987-05-27 | — | — | EP | claimed |
| WO-1987002674-A1 | ANALOGS OF ATRIAL NATRIURETIC PEPTIDES | BIOTECHNOLOGY RESEARCH ASSOCIATES, J.V. (US) | 1987-05-07 | — | — | WO | claimed |
| EP-0213499-A2 | Amino acid derivatives, process for their preparation and use | BOEHRINGER INGELHEIM KG (DE) | 1987-03-11 | — | — | EP | claimed |
| EP-0175323-A2 | Biologically active peptides, processes for preparing them and pharmaceutical compositions | FARMITALIA CARLO ERBA S.r.l. (IT) | 1986-03-26 | — | — | EP | claimed |
| US-4535167-A | CONDENSATION OF ACID AND ALDEHYDE FOLLOWED BY REDUCTIVE CLEAVAGE OF OXAZOLIDINONE INTERMEDIATE | MERCK & CO. INC. (US) | 1985-08-13 | — | — | US | claimed |
| EP-0010297-B1 | DERIVATIVES OF POLYENE MACROLIDE ANTIBIOTICS CONTAINING AN AMINO SUGAR MOIETY, PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING CORPORATION (US) | 1983-04-13 | — | — | EP | claimed |
| US-4232164-A | Purification of AT-125 | THE UPJOHN COMPANY (US) | 1980-11-04 | — | — | US | claimed |
| EP-0010297-A1 | Derivatives of polyene macrolide antibiotics containing an amino sugar moiety, process for the preparation thereof, and pharmaceutical compositions containing them | SCHERING CORPORATION (US) | 1980-04-30 | — | — | EP | claimed |